Cubist Systematic Strategies’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Cubist Systematic Strategies’s Portfolio OMIC Stock Details OMIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-203	Closed	-$5.06K	–	4101
2023 Q2	$5.06K	Buy	+203	New	+$5.95K	﹤0.01%	3310
2023 Q1	–	Sell	-277	Closed	-$16.7K	–	4587
2022 Q4	$16.7K	Sell	277 -424	-60%	-$28.4K	﹤0.01%	4011
2022 Q3	$53K	Sell	701 -506	-42%	-$52.9K	﹤0.01%	4122
2022 Q2	$138K	Sell	1,207 -1,502	-55%	-$176K	﹤0.01%	3851
2022 Q1	$513K	Buy	2,709 +2,159	+393%	+$500K	﹤0.01%	2521
2021 Q4	$191K	Buy	+550	New	+$213K	﹤0.01%	3046

Other funds holding OMIC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cubist Systematic Strategies's OMIC Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q3 2023, closing a stake of 203 shares — an estimated $5.06K sold.

Cubist Systematic Strategies first reported a position in OMIC in Q4 2021 and held it in 6 quarters. The position peaked at $513K in Q1 2022. 48 funds tracked by Wall St. Rank hold OMIC as of Q3 2023.

Cubist Systematic Strategies reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 203 Singular Genomics Systems, Inc. Common Stock shares in Q3 2023, an estimated $5.06K.
Cubist Systematic Strategies first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Cubist Systematic Strategies's Singular Genomics Systems, Inc. Common Stock position peaked at $513K in Q1 2022.
48 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.